Hydrogen Group
Early Clinical Development Lead – Oncology
The Early Clinical Development Lead - Oncology is responsible for shaping and executing the clinical development strategy for early-stage oncology assets. This role provides medical and scientific leadership to advance novel therapies from preclinical through early-phase clinical trials, ensuring alignment with overall program strategy and long-term development goals. Requirements: Medical Degree (M.D.) with board certification in Oncology, Hematology, or a related subspecialty. Minimum of 5 years of direct patient care experience in oncology/hematology. 5+ years of pharmaceutical/biotech industry experience, including at least 2 years in early drug development. Strong understanding of oncology drug development, including small molecules, biologics, and novel modalities. Demonstrated ability to design and lead early-phase clinical trials. Experience interacting with regulatory authorities (FDA, EMA, etc.) and external collaborators. Key Responsibilities Serve as the clinical lead for early-stage oncology programs, providing strategic medical input into program design and execution. Define and implement clinical development strategies from preclinical stage through Phase I/II clinical trials. Oversee study design, protocol development, and medical monitoring to ensure high-quality execution and patient safety. Conduct benefit–risk assessments and provide medical oversight for clinical trials. Collaborate with translational research teams to integrate biomarker strategies and scientific insights into clinical development plans. Seniority level Director Employment type Full-time Job function Science and Research Industries Pharmaceutical Manufacturing Biotechnology Research Hospitals and Health Care
#J-18808-Ljbffr
The Early Clinical Development Lead - Oncology is responsible for shaping and executing the clinical development strategy for early-stage oncology assets. This role provides medical and scientific leadership to advance novel therapies from preclinical through early-phase clinical trials, ensuring alignment with overall program strategy and long-term development goals. Requirements: Medical Degree (M.D.) with board certification in Oncology, Hematology, or a related subspecialty. Minimum of 5 years of direct patient care experience in oncology/hematology. 5+ years of pharmaceutical/biotech industry experience, including at least 2 years in early drug development. Strong understanding of oncology drug development, including small molecules, biologics, and novel modalities. Demonstrated ability to design and lead early-phase clinical trials. Experience interacting with regulatory authorities (FDA, EMA, etc.) and external collaborators. Key Responsibilities Serve as the clinical lead for early-stage oncology programs, providing strategic medical input into program design and execution. Define and implement clinical development strategies from preclinical stage through Phase I/II clinical trials. Oversee study design, protocol development, and medical monitoring to ensure high-quality execution and patient safety. Conduct benefit–risk assessments and provide medical oversight for clinical trials. Collaborate with translational research teams to integrate biomarker strategies and scientific insights into clinical development plans. Seniority level Director Employment type Full-time Job function Science and Research Industries Pharmaceutical Manufacturing Biotechnology Research Hospitals and Health Care
#J-18808-Ljbffr